Search research articles
Contact Us
Filters
Showing results (11-20 of 18) with videos related to
Page
of 2
Sort By:
You have reached the last page of results.
This site can display upto 18 results.
Leukemia
|
November 1, 1988
Impact of reinduction regimens on the clinical course of adult acute nonlymphocytic leukemia
J L Welborn, J P Lewis, F J Meyers
American Family Physician
|
August 1, 1988
Improved approach to patients with normocytic anemia
F J Meyers, J L Welborn, J P Lewis
Cancer Genetics and Cytogenetics
|
October 1, 1987
Diagnostic and prognostic significance of t(1;3)(p36;q21) in the disorders of hematopoiesis
J L Welborn, J P Lewis, H Jenks, et al.
Leukemia Research
|
January 1, 1987
Mast cell disease followed by leukemia with clonal evolution
J P Lewis, J L Welborn, F J Meyers, et al.
Leukemia
|
July 1, 1995
Carboplatin infusion in relapsed and refractory acute myeloid leukemia--a Southwest Oncology Group trial
J L Welborn, K J Kopecky, F J Meyers, et al.
Blood
|
June 15, 1993
HRX involvement in de novo and secondary leukemias with diverse chromosome 11q23 abnormalities
S P Hunger, D C Tkachuk, M D Amylon, et al.
Anticancer Research
|
May 1, 1997
Yttrium-90/indium-111-DOTA-peptide-chimeric L6: pharmacokinetics, dosimetry and initial results in patients with incurable breast cancer
S J Denardo, C M Richman, D S Goldstein, et al.
Blood
|
October 15, 1996
A randomized investigation of high-dose versus standard-dose cytosine arabinoside with daunorubicin in patients with previously untreated acute myeloid leukemia: a Southwest Oncology Group study
J K Weick, K J Kopecky, F R Appelbaum, et al.
Page
of 2
Search research articles
Search
Showing results (11-20 of 18) with videos related to
Sort By:
Page
of 2
You have reached the last page of results.
This site can display upto 18 results.
Leukemia
|
November 1, 1988
Impact of reinduction regimens on the clinical course of adult acute nonlymphocytic leukemia
J L Welborn, J P Lewis, F J Meyers
American Family Physician
|
August 1, 1988
Improved approach to patients with normocytic anemia
F J Meyers, J L Welborn, J P Lewis
Cancer Genetics and Cytogenetics
|
October 1, 1987
Diagnostic and prognostic significance of t(1;3)(p36;q21) in the disorders of hematopoiesis
J L Welborn, J P Lewis, H Jenks, et al.
Leukemia Research
|
January 1, 1987
Mast cell disease followed by leukemia with clonal evolution
J P Lewis, J L Welborn, F J Meyers, et al.
Leukemia
|
July 1, 1995
Carboplatin infusion in relapsed and refractory acute myeloid leukemia--a Southwest Oncology Group trial
J L Welborn, K J Kopecky, F J Meyers, et al.
Blood
|
June 15, 1993
HRX involvement in de novo and secondary leukemias with diverse chromosome 11q23 abnormalities
S P Hunger, D C Tkachuk, M D Amylon, et al.
Anticancer Research
|
May 1, 1997
Yttrium-90/indium-111-DOTA-peptide-chimeric L6: pharmacokinetics, dosimetry and initial results in patients with incurable breast cancer
S J Denardo, C M Richman, D S Goldstein, et al.
Blood
|
October 15, 1996
A randomized investigation of high-dose versus standard-dose cytosine arabinoside with daunorubicin in patients with previously untreated acute myeloid leukemia: a Southwest Oncology Group study
J K Weick, K J Kopecky, F R Appelbaum, et al.
Page
of 2